Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

The H5N1 bird flu virus has historically extracted a heavy toll when it infects humans, with nearly half of confirmed cases ...

Novavax, Inc. (NVAX) on Thursday announced preclinical data demonstrating that the company’s H5N1 bird flu vaccine candidate induced robust immune responses in nonhuman primates. H5N1 is a highly ...

The fatality rate for H5N1 highly pathogenic avian influenza in humans has historically been high, with more than half of ...

Canada does not currently have a bird flu vaccine, but research is underway at the University of Guelph to try and create an ...

The H5N1 avian flu is circulating in cows and other mammals. Whether it will make a permanent leap to humans is another ...

A report from the avian influenza vaccination task force, which looked at how best to manage highly pathogenic avian ...

Biden administration officials said Wednesday they have no current plans to authorize a stockpiled bird flu vaccine, despite an escalating outbreak among livestock in the U.S. and at least 58 ...

The bird flu hit Susie’s Duck Sanctuary in Wahiawa hard, and hundreds of ducks, geese, and other birds had to be euthanized ...

For months, bird flu was seemingly everywhere in the U.S.: news headlines reported the highly pathogenic H5N1 avian influenza ...